According to the latest research published by Future Market Insights, the global enzyme replacement therapy market size is poised to expand at 6.5% CAGR over the forecast period 2022-2028. The global market for enzyme replacement therapy is expected to exceed US$ 13,776.2 Mn by 2028 end, attesting the highest growth rate by Japan, which is expected to expand at 12.5% CAGR over 2022-2028.

Increasing per capita healthcare expenditure in North America is expected to push market revenue growth. The rapidly developing healthcare infrastructure and increasing awareness programmes in the highly populous regions of Asia Pacific and China is expected to play an important role in driving revenue growth of the global enzyme replacement therapy market.

Companies in the global ERT market are focussing on strategic initiatives such as alliances and agreements, collaborations, increasing R&D activities, new product launches, joint ventures, partnerships, and mergers & acquisitions to sustain in the competitive global market.

Key Research Findings

Enzyme replacement therapy is used in the treatment of rare diseases and the global market is projected to create incremental opportunity of US$ 6,448.3 Mn between 2022 and 2028

When compared to other established markets such as North America, the enzyme replacement therapy markets in Japan and Western Europe are expected to witness fast and steady growth, partly due to the increasing governmental support and growing demand for enzyme replacement therapy for the treatment of rare diseases.

Global Enzyme Replacement Therapy Market: Competitive Landscape

The global market is highly consolidated owing to the presence of several players. Some of the key players are Sanofi (Genzyme Corporation), Shire, Pfizer, Inc., Alexion Pharmaceuticals, Inc., BioMarin Pharmaceutical, Inc., Ultragenyx Pharmaceutical, Inc., Johnson & Johnson Services, Inc., Allergan, Leadiant Biosciences, Inc., and others.

Key Segments of Enzyme Replacement Therapy Industry Survey

Enzyme Replacement Therapy Market by Therapeutic Condition:

Enzyme Replacement Therapy for Fabry Disease
Enzyme Replacement Therapy for Gaucher Disease
Enzyme Replacement Therapy for Mucopolysaccharidosis
Enzyme Replacement Therapy for Pompe Disease
Enzyme Replacement Therapy for Lysosomal Acid Lipase Deficiency
Others
Enzyme Replacement Therapy Market by Route of Administration:

Oral Enzyme Replacement Therapy
Injectable Enzyme Replacement Therapy
Enzyme Replacement Therapy Market by Distribution Channel:

Hospital Pharmacies
Specialty Treatment Pharmacies
Retail Pharmacies
Enzyme Replacement Therapy Market by Region:

North America Enzyme Replacement Therapy Market
Latin America Enzyme Replacement Therapy Market
Europe Enzyme Replacement Therapy Market
East Asia Enzyme Replacement Therapy Market
South Asia & Pacific Enzyme Replacement Therapy Market
Middle East & Africa (MEA) Enzyme Replacement Therapy Market
Information Source: https://www.futuremarketinsights.com/reports/enzyme-replacement-therapy-market